Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep336 | Clinical case reports - Thyroid/Others | ECE2016

Mixed gonadal dygenesia report of a mosaicism 45,X/46,XY, mexican case report

Rodriguez Nory Omayra Davalos , Pulido Jose Antonio Escalante , Magallanes-Ordonez Jose de Jesus , Ramirez-Arechiga Celia Andrea , Cervantes-Perez Enrique , Ruano Martha Alice Delgadillo , Gomez Julio Cesar , Rodriguez Ingrid Patricia Davalos , Villanueva Luis Eduardo Figueroa , Ramirez-Garcia Sergio Alberto , Angulo Melva Gutierrez , Madrigal Maria de la Luz Ayala , Sanchez Ana Rosa Rincon

Introduction: The Disorders of Sex Development (DSDs) may arise from various genetic disorders therefore cytogenetic studies are necessary to determine the chromosomal sex. The 45,X/46,XY karyotype is considered a mixed gonadal dysgenesis (MGD) and the mosaicism in this condition has a low incidence: 1.5 per 10 000 newborns, characterized by a broad phenotypic spectrum.Objective: The aim of this report is to present a mexican newborn female patient with ...

ea0041ep885 | Pituitary - Clinical | ECE2016

What is the outcome of nonfunctioning pituitary adenomas (NFPAs) after surgery and are there any factors to predict it: a multicenter study in Northern Spain

Galiana Rodriguez Caballero Maria , Valdes Gallego Nuria , Ares Jessica , Larranaga Ihintza , Hernandez Morhain Cecilia , Ollero Dolores , Gaztambide Sonia , Isasa Leire , Forga Lluis , Mouritz Marta , Suarez Lorena , Rodriguez Rosa , Corte Daniela , Delgado Elias , Sanchez Ragnarsson Cecilia , Suarez Lorena , Cacho Laura , Pertierra Joaquin , Rabal Antonio , Menendez Edelmiro

Introduction: There is scarcity of data on the recurrence and/or progression (R/P) rate in nonfunctioning pituitary adenomas (NFPAs) after surgery and the risk factors that can predict this outcome. So the aim of this study was to analyze a large series of NFPAs with a long follow-up after surgery, focusing on the evaluation of R/P rate and the risk factors associated with it.Methods: Retrospective cohort analysis of 164 patients with NFPAs from 3 differ...

ea0081rc6.1 | Rapid Communications 6: Endocrine-Related Cancer | ECE2022

Clinical relevance of body composition measurement at L3 level in gastroenteropancreatic neuroendocrine tumors

Sebastian Valles Fernando , Sanchez de la Blanca Carrero Nuria , Rodriguez Laval Victor , Knott Torcal Carolina , Serrano-Somavilla Ana , Martinez-Hernandez Rebeca , Martin-Perez Elena , Munozde Nova Jose Luis , Marazuela Monica , Sampedro-Nunez Miguel

Introduction: Nutritional status in patients with neuroendocrine tumors (NETs), especially with gastroenteropancreatic origin, may be affected and have an impact on prognosis and survival. Different techniques are currently available to assess nutritional status, but not all of them are accessible in routine clinical practice. In this context, Body composition of NET patients was calculated by computed tomography (CT) at L3 level to evaluate its importance on clinical prognosi...

ea0081p4 | Adrenal and Cardiovascular Endocrinology | ECE2022

Patients with chronic kidney disease present HPA axis disregulation due to impaired glucocorticoid negative feedback

Boswell Laura , Blasco Miquel , Quintana Luis F. , Vega-Beyhart Arturo , Viaplana Judith , Rodriguez Gabriela , Diaz Daniela , Vilardell Carme , Mora Mireia , Halperin Irene , Amor Antonio J. , Casals Gregori , Hanzu Felicia A.

Aims: A few studies have shown disturbances in the hypothalamic-pituitary-adrenal (HPA) axis in chronic-kidney-disease (CKD), of unknown extent and clinical implications. We aimed to study the HPA axis in patients with CKD and its association with kidney impairment and metabolic disturbances.Methods: Cross-sectional controlled study. Patients with CKD stages I-II (estimated glomerular filtration rate [eGFR] through CKD-EPI equation >60), stage III (e...

ea0081p324 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Characterization of the somatostatin and ghrelin hormonal systems revealed their potential therapeutic role in chronic liver disease

Herman Sanchez Natalia , Luis Lopez-Canovas Juan , Garcia-Estrada Antonio , Saez-Martinez Prudencio , Amado Victor , de la Mata Manuel , Cordoba-Chacon Jose , Sarmento-Cabral Andra , Rodriguez-Peralvarez Manuel , Luque Raul M. , Gahete Manuel D.

Hormonal signalling plays a key role in the progression of metabolic (dysfunction)-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC). However, the role of somatostatin (SST), cortistatin (CORT), neuronostatin (NST) and ghrelin systems in MAFLD-HCC progression has not yet been elucidated. We characterized the role of SST/CORT/NST and ghrelin systems in chronic liver disease and evaluated their clinical potential. The expression of the components of the SS...

ea0081p362 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Morphofunctional assessment of cancer patient’s nutritional status receiving systemic treatment and oral nutritional supplements

Leon-Idougourram Soraya , Garcia-Ramirez Mireia , Manuel Alzas-Teomiro Carlos , Manzano-Garcia Gregorio , Munoz-Jimanez Concepcion , Jesus Calanas-Continente Alfonso , Rodriguez-Alonso Rosa , Molina-Puerta Maria Josa , Angeles Galvez-Moreno Maria , Herrera-Martinez Aura Dulceida

Introduction: Disease-related malnutrition is one of the main factors associated with morbidity and mortality in cancer patients. Furthermore, maintaining and improving muscle mass and function are important to achieve an optimal nutritional status. In this sense, the role of leucine-enriched essential amino acids supplementation for the therapeutic approach to the promotion of muscle anabolism stands out.Methods: 46 cancer patients with malnutrition rec...

ea0081p173 | Pituitary and Neuroendocrinology | ECE2022

The immune microenvironment landscape in pituitary tumors, genes and cells

Vela Patino Sandra , Isabel Salazar Ma. , Remba-Shapiroa Ilan , Pena-Martinez Eduardo , Silva-Roman Gloria , Andoneui-Elguera Sergio , Taniguchi-Ponciano Keiko , Bonifaz Laura , Aguilar-Flores Cristina , Mercado Moises , Marrero-Rodriguez Daniel

The tumor immune microenvironment is essential, it could influence a favorable or negative response against the tumor cells, and it has been related to therapy response and prognostic factors. Tumor infiltrating lymphocytes (TILs) plays an important role in the development, progression, and tumor control, thus presence of TILs could be related to disease-specific traits. The aim of the present work is to evaluate the expression of immune-related genes in forty-two pituitary ad...

ea0050oc1.3 | Early Career Oral Communications | SFEBES2017

Antioxidant pathway targeting as a therapeutic approach in adrenocortical carcinoma

Chortis Vasileios , Taylor Angela E. , Doig Craig L. , Meimaridou Eirini , Walsh Mark , Jenkinson Carl , Rodriguez-Blanco Giovanny , Jafri Alisha , Ronchi Cristina , Metherell Louise A. , Hebenstreit Daniel , Dunn Warwick B. , Arlt Wiebke , Foster Paul A.

Adrenocortical Carcinoma (ACC) is an aggressive malignancy with poor response to chemotherapy. Here we evaluated a potential new treatment target for ACC, focusing on the mitochondrial NADPH generator Nicotinamide Nucleotide Transhydrogenase (NNT). NNT has a central role within the mitochondrial antioxidant pathways, protecting cells from oxidative stress. Inactivating NNT mutations lead to isolated primary adrenal insufficiency, suggesting a selective vulnerability of adrenoc...

ea0050oc1.3 | Early Career Oral Communications | SFEBES2017

Antioxidant pathway targeting as a therapeutic approach in adrenocortical carcinoma

Chortis Vasileios , Taylor Angela E. , Doig Craig L. , Meimaridou Eirini , Walsh Mark , Jenkinson Carl , Rodriguez-Blanco Giovanny , Jafri Alisha , Ronchi Cristina , Metherell Louise A. , Hebenstreit Daniel , Dunn Warwick B. , Arlt Wiebke , Foster Paul A.

Adrenocortical Carcinoma (ACC) is an aggressive malignancy with poor response to chemotherapy. Here we evaluated a potential new treatment target for ACC, focusing on the mitochondrial NADPH generator Nicotinamide Nucleotide Transhydrogenase (NNT). NNT has a central role within the mitochondrial antioxidant pathways, protecting cells from oxidative stress. Inactivating NNT mutations lead to isolated primary adrenal insufficiency, suggesting a selective vulnerability of adrenoc...

ea0090oc7.3 | Oral Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

The mesenchymal stem cells induce immunosuppressive microenvironment in pituitary tumors

Marrero-Rodriguez Daniel , Taniguchi Keiko , A Cortes-Morales Victor , Valenzuela-Perez Alejandra , Vela-Patino Sandra , Cano-Zaragoza Amayrani , Martinez Florencia , Kerbel Jacobo , Andonegui-Elguera Sergio , Gomez-Apo Erick , Chavez-Macias Laura , Montesinos Juan Jose , Mercado Moises

The tumor microenvironment (TME) includes diverse cellular components such as mesenchymal stem cells (MSC) and immune cells. MSC are a subset of heterogeneous cell populations characterized by the expression of CD105, CD73, and CD90 that can differentiate into chondrocytes, osteoblasts, and adipocytes in vitro. They are known to have immunomodulatory capabilities. Our aim was to isolate and characterize the immunomodulatory capabilities of MSC from pituitary tumors (P...